Business Introduction: GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our p...
Territory to include, but not limited to, Sacramento and the surrounding suburbs up to Chico in the north and Truckee to the east and Vacaville to the west. For more than 140 years, GSK has pioneered novel research methods and technologie...
The Onyx Research Data Tech organization represents a major investment by GSK R&D and Digital & Tech, designed to deliver a step-change in our ability to leverage data, knowledge, and prediction to find new medicines. We are a full-stack sh...
At GSK Cambridge, we’re seeking an experienced Occupational Health Nurse Practitioner to lead and grow our occupational health services across our Massachusetts sites from our new Cambridge Park Drive location - elevating care for our peopl...
We manufacture and supply reliable, high-quality medicines and vaccines to meet patients’ needs and drive our performance. Our network of 37 medicines and vaccines manufacturing sites delivered 1.7 billion packs of medicines and 409 milli...
We manufacture and supply reliable, high‑quality medicines to meet patients’ needs and drive performance. Our network of manufacturing partners and sites deliver medicines globally — and packaging technology is critical to ensuring product ...
At GSK, we want to supercharge our data capability to better understand our patients and accelerate our ability to discover vaccines and medicines. The Onyx Research Data Platform organization represents a major investment by GSK R&D and Di...
The Human Resources Business Partner will play a pivotal role in the delivery of key HR initiatives which support the business strategy and improves business performance. The Human Resources Business Partner will coach business leaders in t...
was created as a joint venture by Pfizer and GlaxoSmithKline in November 2009 with both companies transferring their HIV assets... to the new company. In 2012 Shionogi joined the company. 76.5% of the company is now owned by GlaxoSmithKline...
was created as a joint venture by Pfizer and GlaxoSmithKline in November 2009 with both companies transferring their HIV assets... to the new company. In 2012 Shionogi joined the company. 76.5% of the company is now owned by GlaxoSmithKline...